Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia

S. Fukumori, Y. Tsuji, A. Mizoguchi, H. Kasai, T. Ishibashi, N. Iwamura, H. To

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

What is known and objective: The pharmacokinetic–pharmacodynamic parameter that best predicts the efficacy of vancomycin is the ratio of the area under the concentration versus time curve (AUC) to the minimum inhibitory concentration (MIC). A 24-h AUC (AUC24)/MIC ratio ≥ 400 was recommended in an American consensus review, but vancomycin treatment occasionally fails despite maintenance of AUC24/MIC ≥ 400. We evaluated the association between clinical efficacy of vancomycin and two novel pharmacokinetic parameters, the ‘area under the trough level’ (AUTL) and the ‘area above the trough level’ (AATL), in hospitalized elderly patients with methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. Methods: The subjects were hospitalized elderly patients who were administered vancomycin for treatment of MRSA pneumonia between 2006 and 2012 at Sasebo Chuo Hospital (Nagasaki, Japan). Pharmacokinetic parameters of vancomycin were estimated for each patient by Bayesian analysis using population pharmacokinetic parameters for Japanese patients. Based on the patient-specific parameters thus obtained, AUC24 values were calculated as the vancomycin dosage divided by vancomycin clearance. AUTL was calculated as the trough serum concentration multiplied by 24 h, whereas AATL was calculated by subtracting AUTL from AUC24. Results and discussion: Logistic regression analysis demonstrated that efficacy of vancomycin was more strongly associated with AUTL than AUC24. The optimal cut-off value of AUTL was 331 μg∙h/mL, which means that the optimal cut-off value of the trough serum concentration was 13·8 μg/mL. What is new and conclusion: Efficacy of vancomycin was associated with AUTL, a novel pharmacokinetic parameter. Determining the target AUTL or trough concentration may enhance the efficacy of vancomycin therapy in elderly patients with MRSA pneumonia. Given that nephrotoxicity may increase with a Ctrough in excess of 15 μg/mL, this level should ideally not be exceeded.

Original languageEnglish
Pages (from-to)399-402
Number of pages4
JournalJournal of Clinical Pharmacy and Therapeutics
Volume41
Issue number4
DOIs
Publication statusPublished - 2016 Aug 1
Externally publishedYes

Fingerprint

Vancomycin
Pneumonia
Pharmacokinetics
Staphylococcal Pneumonia
Methicillin-Resistant Staphylococcus aureus
Microbial Sensitivity Tests
Area Under Curve
Bayes Theorem
Serum
Japan
Therapeutics
Logistic Models
Regression Analysis
Maintenance

Keywords

  • MRSA
  • pharmacokinetic parameter
  • therapeutic drug monitoring
  • vancomycin

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia. / Fukumori, S.; Tsuji, Y.; Mizoguchi, A.; Kasai, H.; Ishibashi, T.; Iwamura, N.; To, H.

In: Journal of Clinical Pharmacy and Therapeutics, Vol. 41, No. 4, 01.08.2016, p. 399-402.

Research output: Contribution to journalArticle

@article{6b0e8fb9067e42309e682810597627d1,
title = "Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia",
abstract = "What is known and objective: The pharmacokinetic–pharmacodynamic parameter that best predicts the efficacy of vancomycin is the ratio of the area under the concentration versus time curve (AUC) to the minimum inhibitory concentration (MIC). A 24-h AUC (AUC24)/MIC ratio ≥ 400 was recommended in an American consensus review, but vancomycin treatment occasionally fails despite maintenance of AUC24/MIC ≥ 400. We evaluated the association between clinical efficacy of vancomycin and two novel pharmacokinetic parameters, the ‘area under the trough level’ (AUTL) and the ‘area above the trough level’ (AATL), in hospitalized elderly patients with methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. Methods: The subjects were hospitalized elderly patients who were administered vancomycin for treatment of MRSA pneumonia between 2006 and 2012 at Sasebo Chuo Hospital (Nagasaki, Japan). Pharmacokinetic parameters of vancomycin were estimated for each patient by Bayesian analysis using population pharmacokinetic parameters for Japanese patients. Based on the patient-specific parameters thus obtained, AUC24 values were calculated as the vancomycin dosage divided by vancomycin clearance. AUTL was calculated as the trough serum concentration multiplied by 24 h, whereas AATL was calculated by subtracting AUTL from AUC24. Results and discussion: Logistic regression analysis demonstrated that efficacy of vancomycin was more strongly associated with AUTL than AUC24. The optimal cut-off value of AUTL was 331 μg∙h/mL, which means that the optimal cut-off value of the trough serum concentration was 13·8 μg/mL. What is new and conclusion: Efficacy of vancomycin was associated with AUTL, a novel pharmacokinetic parameter. Determining the target AUTL or trough concentration may enhance the efficacy of vancomycin therapy in elderly patients with MRSA pneumonia. Given that nephrotoxicity may increase with a Ctrough in excess of 15 μg/mL, this level should ideally not be exceeded.",
keywords = "MRSA, pharmacokinetic parameter, therapeutic drug monitoring, vancomycin",
author = "S. Fukumori and Y. Tsuji and A. Mizoguchi and H. Kasai and T. Ishibashi and N. Iwamura and H. To",
year = "2016",
month = "8",
day = "1",
doi = "10.1111/jcpt.12399",
language = "English",
volume = "41",
pages = "399--402",
journal = "Journal of Clinical Pharmacy and Therapeutics",
issn = "0269-4727",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia

AU - Fukumori, S.

AU - Tsuji, Y.

AU - Mizoguchi, A.

AU - Kasai, H.

AU - Ishibashi, T.

AU - Iwamura, N.

AU - To, H.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - What is known and objective: The pharmacokinetic–pharmacodynamic parameter that best predicts the efficacy of vancomycin is the ratio of the area under the concentration versus time curve (AUC) to the minimum inhibitory concentration (MIC). A 24-h AUC (AUC24)/MIC ratio ≥ 400 was recommended in an American consensus review, but vancomycin treatment occasionally fails despite maintenance of AUC24/MIC ≥ 400. We evaluated the association between clinical efficacy of vancomycin and two novel pharmacokinetic parameters, the ‘area under the trough level’ (AUTL) and the ‘area above the trough level’ (AATL), in hospitalized elderly patients with methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. Methods: The subjects were hospitalized elderly patients who were administered vancomycin for treatment of MRSA pneumonia between 2006 and 2012 at Sasebo Chuo Hospital (Nagasaki, Japan). Pharmacokinetic parameters of vancomycin were estimated for each patient by Bayesian analysis using population pharmacokinetic parameters for Japanese patients. Based on the patient-specific parameters thus obtained, AUC24 values were calculated as the vancomycin dosage divided by vancomycin clearance. AUTL was calculated as the trough serum concentration multiplied by 24 h, whereas AATL was calculated by subtracting AUTL from AUC24. Results and discussion: Logistic regression analysis demonstrated that efficacy of vancomycin was more strongly associated with AUTL than AUC24. The optimal cut-off value of AUTL was 331 μg∙h/mL, which means that the optimal cut-off value of the trough serum concentration was 13·8 μg/mL. What is new and conclusion: Efficacy of vancomycin was associated with AUTL, a novel pharmacokinetic parameter. Determining the target AUTL or trough concentration may enhance the efficacy of vancomycin therapy in elderly patients with MRSA pneumonia. Given that nephrotoxicity may increase with a Ctrough in excess of 15 μg/mL, this level should ideally not be exceeded.

AB - What is known and objective: The pharmacokinetic–pharmacodynamic parameter that best predicts the efficacy of vancomycin is the ratio of the area under the concentration versus time curve (AUC) to the minimum inhibitory concentration (MIC). A 24-h AUC (AUC24)/MIC ratio ≥ 400 was recommended in an American consensus review, but vancomycin treatment occasionally fails despite maintenance of AUC24/MIC ≥ 400. We evaluated the association between clinical efficacy of vancomycin and two novel pharmacokinetic parameters, the ‘area under the trough level’ (AUTL) and the ‘area above the trough level’ (AATL), in hospitalized elderly patients with methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. Methods: The subjects were hospitalized elderly patients who were administered vancomycin for treatment of MRSA pneumonia between 2006 and 2012 at Sasebo Chuo Hospital (Nagasaki, Japan). Pharmacokinetic parameters of vancomycin were estimated for each patient by Bayesian analysis using population pharmacokinetic parameters for Japanese patients. Based on the patient-specific parameters thus obtained, AUC24 values were calculated as the vancomycin dosage divided by vancomycin clearance. AUTL was calculated as the trough serum concentration multiplied by 24 h, whereas AATL was calculated by subtracting AUTL from AUC24. Results and discussion: Logistic regression analysis demonstrated that efficacy of vancomycin was more strongly associated with AUTL than AUC24. The optimal cut-off value of AUTL was 331 μg∙h/mL, which means that the optimal cut-off value of the trough serum concentration was 13·8 μg/mL. What is new and conclusion: Efficacy of vancomycin was associated with AUTL, a novel pharmacokinetic parameter. Determining the target AUTL or trough concentration may enhance the efficacy of vancomycin therapy in elderly patients with MRSA pneumonia. Given that nephrotoxicity may increase with a Ctrough in excess of 15 μg/mL, this level should ideally not be exceeded.

KW - MRSA

KW - pharmacokinetic parameter

KW - therapeutic drug monitoring

KW - vancomycin

UR - http://www.scopus.com/inward/record.url?scp=84976546347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976546347&partnerID=8YFLogxK

U2 - 10.1111/jcpt.12399

DO - 10.1111/jcpt.12399

M3 - Article

C2 - 27144370

AN - SCOPUS:84976546347

VL - 41

SP - 399

EP - 402

JO - Journal of Clinical Pharmacy and Therapeutics

JF - Journal of Clinical Pharmacy and Therapeutics

SN - 0269-4727

IS - 4

ER -